Red Cell forms Zephyr AI

By The Science Advisory Board staff writers

November 23, 2021 -- Red Cell has formed Zephyr AI to transform drug discovery and precision medicine through the integration of artificial intelligence (AI).

Zephyr integrates AI with extensive datasets discover new therapies, applications for existing therapeutics, and advanced biomarkers for individualized treatments.

The company is co-founded by Yisroel Brumer, PhD, formerly of the Office of the Secretary of Defense; Grant Verstandig, former CEO of Rally Health; and Jeff Sherman, former machine learning architect at Rally Health.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.